RBPJ and neoplasm: To determine if this tumor regression by IKKβ inhibition is affected by Rbpj status, we treated WAP-Int3/Rbpj−/− tumor-bearing mice with 20 mg/week IMD-0354 for one week and monitored tumor weight (TW) daily.